283 related articles for article (PubMed ID: 26061547)
21. The roles of neutrophil serine proteinases in idiopathic inflammatory myopathies.
Gao S; Zuo X; Liu D; Xiao Y; Zhu H; Zhang H; Luo H
Arthritis Res Ther; 2018 Jul; 20(1):134. PubMed ID: 29976235
[TBL] [Abstract][Full Text] [Related]
22. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
24. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
25. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro.
Berger SP; Seelen MA; Hiemstra PS; Gerritsma JS; Heemskerk E; van der Woude FJ; Daha MR
J Am Soc Nephrol; 1996 May; 7(5):694-701. PubMed ID: 8738804
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
27. Local structural plasticity of the
Herdendorf TJ; Stapels DAC; Rooijakkers SHM; Geisbrecht BV
J Biol Chem; 2020 May; 295(22):7753-7762. PubMed ID: 32303641
[TBL] [Abstract][Full Text] [Related]
28. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
Garwicz D; Lennartsson A; Jacobsen SE; Gullberg U; Lindmark A
Haematologica; 2005 Jan; 90(1):38-44. PubMed ID: 15642667
[TBL] [Abstract][Full Text] [Related]
29. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.
Adkison AM; Raptis SZ; Kelley DG; Pham CT
J Clin Invest; 2002 Feb; 109(3):363-71. PubMed ID: 11827996
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.
Yang JJ; Kettritz R; Falk RJ; Jennette JC; Gaido ML
Am J Pathol; 1996 Nov; 149(5):1617-26. PubMed ID: 8909251
[TBL] [Abstract][Full Text] [Related]
31. Protection of lung epithelial cells from protease-mediated injury by trappin-2 A62L, an engineered inhibitor of neutrophil serine proteases.
Tanga A; Saidi A; Jourdan ML; Dallet-Choisy S; Zani ML; Moreau T
Biochem Pharmacol; 2012 Jun; 83(12):1663-73. PubMed ID: 22465040
[TBL] [Abstract][Full Text] [Related]
32. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
33. Specific sensitivity of CD43 to neutrophil elastase.
Remold-O'Donnell E; Parent D
Blood; 1995 Sep; 86(6):2395-402. PubMed ID: 7662987
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
35. Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease.
Cooley J; McDonald B; Accurso FJ; Crouch EC; Remold-O'Donnell E
J Leukoc Biol; 2008 Apr; 83(4):946-55. PubMed ID: 18211966
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
Méthot N; Rubin J; Guay D; Beaulieu C; Ethier D; Reddy TJ; Riendeau D; Percival MD
J Biol Chem; 2007 Jul; 282(29):20836-46. PubMed ID: 17535802
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor.
Renesto P; Si-Tahar M; Moniatte M; Balloy V; Van Dorsselaer A; Pidard D; Chignard M
Blood; 1997 Mar; 89(6):1944-53. PubMed ID: 9058715
[TBL] [Abstract][Full Text] [Related]
38. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation.
Bank U; Reinhold D; Schneemilch C; Kunz D; Synowitz HJ; Ansorge S
J Interferon Cytokine Res; 1999 Nov; 19(11):1277-87. PubMed ID: 10574621
[TBL] [Abstract][Full Text] [Related]
39. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
40. The effect of neutrophil serine proteases on human nasal epithelial cell barrier function.
Kao SS; Ramezanpour M; Bassiouni A; Wormald PJ; Psaltis AJ; Vreugde S
Int Forum Allergy Rhinol; 2019 Oct; 9(10):1220-1226. PubMed ID: 31403754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
